Sildenafil Tablet, Film Coated
Product Images NDC 50090-6804

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-6804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500906804)

Label Image (Lbl500906804)
Label for SILDENAFIL 50 mg film-coated tablets manufactured by A-S Medication Solutions. The label includes drug quantity (10 tablets), storage instructions to store at 77 degrees Fahrenheit, and directions to see the package insert for dosing. It also shows the product NDC number 50090-6804 and identifies the active ingredient sildenafil citrate equivalent to 50 mg sildenafil.*
FDA Label Image

Sildenafil Citrate Structure (Sildenafil Tabs Usp Chem Structure)

Sildenafil Citrate Structure (Sildenafil Tabs Usp Chem Structure)
Chemical structure of sildenafil, the active ingredient in SILDENAFIL 50 mg tablets by A-S Medication Solutions. The structure depicts the molecular arrangement of atoms characteristic of sildenafil.*
FDA Label Image

Figure 1 (Sildenafil Tabs Usp Figure 1)

Figure 1 (Sildenafil Tabs Usp Figure 1)
A line graph comparing the effect of two treatments on systolic blood pressure over 24 hours. The x-axis represents time post-dose in hours, ranging from pre-dose to 24 hours, and the y-axis shows systolic blood pressure changes in mm Hg. One line represents sildenafil 100 mg and the other placebo, illustrating variations in systolic blood pressure at different time points post-dose.*
FDA Label Image

Figure 2 (Sildenafil Tabs Usp Figure 2)

Figure 2 (Sildenafil Tabs Usp Figure 2)
A line graph showing the change in systolic blood pressure (SBP) over time post dose, in hours (0 to 8). Two lines represent data for Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg, indicating trends in SBP changes in mmHg for each treatment group.*
FDA Label Image

Figure 3 (Sildenafil Tabs Usp Figure 3)

Figure 3 (Sildenafil Tabs Usp Figure 3)
A line graph illustrating change in systolic blood pressure (SBP) over time post-dose in hours for two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The y-axis shows change in SBP (mmHg), and the x-axis shows time post dose (hours). Two data series are plotted with distinctive markers.*
FDA Label Image

Figure 4 (Sildenafil Tabs Usp Figure 4)

Figure 4 (Sildenafil Tabs Usp Figure 4)
A line graph depicting blood pressure changes (mmHg) over time (hours) after dosing. It compares the effects of two treatments: Doxazosin combined with Sildenafil 100 mg and Doxazosin combined with Placebo, showing values from 0 to 8 hours post-dose.*
FDA Label Image

Figure 5 (Sildenafil Tabs Usp Figure 5)

Figure 5 (Sildenafil Tabs Usp Figure 5)
A pharmacokinetic curve chart showing plasma concentration (ng/mL) of the active ingredient over time post dose (hours) for sildenafil. It compares the plasma levels of the commercial tablet formulation, tracked from 0 to 24 hours after administration.*
FDA Label Image

Figure 6 (Sildenafil Tabs Usp Figure 6)

Figure 6 (Sildenafil Tabs Usp Figure 6)
A bar chart titled 'Effect of Sildenafil on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint on the vertical axis and baseline score on the horizontal axis ranging from 0 to 5. The chart includes multiple bars for each baseline score, labeled 0 through 5 in a legend, illustrating varying percentages of patients at each endpoint score.*
FDA Label Image

Figure 7 (Sildenafil Tabs Usp Figure 7)

Figure 7 (Sildenafil Tabs Usp Figure 7)
A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score' depicting the percentage of patients at endpoint on the vertical axis and baseline score on the horizontal axis. Multiple bars in different shades represent categories from 0 to 5, showing distribution of patient response across baseline erection scores.*
FDA Label Image

Figure 8 (Sildenafil Tabs Usp Figure 8)

Figure 8 (Sildenafil Tabs Usp Figure 8)
A bar graph showing the percentage of patients reporting improvement across treatment groups including Placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The y-axis represents percentage improvement, and the x-axis lists the treatment groups with sample sizes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.